Cannabinoids
Chemical compounds derived from the cannabis plant, including CBD and THC, subject to safety evaluations, concentration limits, and purity standards in cosmetics, food, and supplements.
Foresight tracks Cannabinoids developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
Intensifying
33% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
10 May 2026, 19:19
Latest Cannabinoids alerts
The most recent regulatory and guidance signals tracked by Foresight
Vermont S.323 Moves to House Ways and Means, Proposing Pesticide, Seed, and Hemp Regulatory Changes
In May 2026, Vermont’s omnibus agriculture bill S.323, which bundles significant changes to pesticide applicator licensing, seed labelling and reporting, hemp regulation, and farm permitting, passed the Senate and advanced to the House Ways and Means Committee. If enacted with its current text from July 2026, these reforms would tighten data and oversight requirements for pesticide-treated and genetically engineered seeds, bring many hemp-derived cannabinoids under stricter cannabis-style controls, and reshape compliance duties and costs for farms, agri‑businesses, and energy developers operating in Vermont.
South Carolina Bill H.5667 Would Create Apothecary Retailer Licences for Hemp-Derived Cannabinoid and Wellness Products
South Carolina has introduced Bill H.5667 (Apothecary Retailer Act) to create a new apothecary retailer licence category and impose age, THC-content and marketing controls on hemp-derived cannabinoid, smoking-cession and wellness products sold in specialist outlets. If enacted, this would establish a distinct retail channel outside alcohol law, requiring manufacturers and retailers of cannabinoid and wellness products to align product formulations, labelling, and distribution strategies with South Carolina-specific THC limits and age-verification rules.
Connecticut HB 5350 (Public Act 26-8) Overhauls Cannabis, Hemp and Infused Beverage Regulation
Connecticut has advanced HB 5350 (now recorded as Public Act 26-8) to the final legislative stage, enacting wide-ranging statutory changes to cannabis, hemp, and infused beverage regulation that largely take effect from October 2026. These amendments reset THC and testing rules, expand permissible product types, tighten retailers’ data and credit practices, and create new licensing and tracking for hemp-derived extracts, requiring cannabis and beverage businesses to update formulations, lab arrangements, packaging, and compliance systems ahead of the effective date.
Delaware HB 373 Moves To House Appropriations Committee On THC-Infused Beverages
In early May 2026, Delaware advanced HB 373, a bill to create a regulatory and tax framework for THC-infused beverages and to reclassify certain cannabinoids, by moving it from the Economic Development committee to the House Appropriations Committee. If ultimately enacted, the measure would impose new manufacturing, testing, record-keeping, packaging, age-restriction and excise tax obligations on THC beverage and cannabis businesses in Delaware, so affected companies should monitor the bill’s appropriations review and prepare for a possible 90-day post-enactment implementation window.
Delaware Legislature Introduces Delaware Hemp Regulation Act for Hemp-Derived Cannabinoid Products (HB 401)
Delaware has introduced HB 401 to establish the Delaware Hemp Regulation Act, creating a comprehensive licensing, testing, labelling, and taxation framework for retail sales of hemp-derived cannabinoid products to adults 21 and over. If enacted, this would significantly tighten controls on hemp-derived cannabinoids in Delaware, requiring new testing and packaging compliance, age-gated retail operations, and readiness for a 6% excise tax within a year of enactment or final regulations.
Delaware HB 395 Would Tighten Regulation of Intoxicating THC Consumable Products
Delaware House Bill 395 would amend state hemp and marijuana laws to bring intoxicating THC consumable products under the licensed adult-use marijuana regulatory framework. If enacted, retailers would need to channel higher-THC consumables through licensed outlets and meet stricter testing, labelling, packaging and age-restriction rules, reducing unregulated sales and exposure to minors.
EU Parliament Receives Draft Commission Regulations on Pesticide MRLs and Food Contaminants
European Commission draft regulations to amend pesticide maximum residue levels and food contaminant limits have been forwarded to the European Parliament’s ENVI committee under the regulatory procedure with scrutiny, with objection deadlines in June 2026. If they proceed, revised limits for specified pesticides, process contaminants and delta-9-THC in hemp food products will apply across the EU, requiring food and agriculture businesses to confirm future product and sourcing compliance.
EESC Opinion on Proposal to Amend Regulation (EU) No 1308/2013 (School Scheme, Protein Crops, Hemp and Marketing Standards)
In January 2026 the European Economic and Social Committee issued an opinion on the CMO reform proposal COM(2025)553, covering EU school food schemes, a new protein crops sector, hemp production rules, marketing standards and agri-food crisis preparedness. If taken up by the co-legislators, its recommendations would support risk-based regulation of hemp (including THC/CBD feed uses), stronger origin labelling and protected meat designations, and clearer timelines for transitioning EU school schemes and agri-food crisis mechanisms, reshaping planning for agricultural, food and hemp supply chains.
EU SCCS Issues Scientific Advice on Safe Use Levels of Cannabidiol (CBD) and THC in Cosmetic Products
In April 2026, the EU Scientific Committee on Consumer Safety issued final scientific advice setting safe use levels for CBD and trace THC in cosmetic products. These quantitative limits will now anchor EU safety assessments for CBD cosmetics, so brands using higher concentrations or hemp-derived materials must reassess formulations, impurity controls, and aggregate exposure across dermal and oral products.
Norway Publishes Joint Guidance on CBD Rules Across Product Categories
Norway’s food and medicines regulators have issued joint guidance confirming that cannabis-derived CBD extracts remain classified as narcotics and that CBD is still banned in foods, drinks and supplements, with only tightly controlled uses in medicines and certain cosmetics using synthetic CBD. This consolidates existing EU and national rules and signals continued strict enforcement, so businesses selling CBD products in Norway need to reassess product portfolios, labelling and supply chains to avoid illegal offerings and potential seizures or sanctions.
Oklahoma Senate Passes HB 4248 to Prohibit Sale of Hemp Beverages to Persons Under 21
The Oklahoma Senate has now passed HB 4248, a bill that would bar sales of hemp‑containing beverages to anyone under 21, with a planned effective date of 1 November 2026 if enacted. Companies selling hemp drinks into Oklahoma should prepare to treat them as age‑restricted products, updating point‑of‑sale controls and retailer guidance well before the proposed effective date.
EFSA Resumes Risk Assessment and Updates June 2026 Deadline for Cannabidiol Novel Food Application
EFSA has resumed its risk assessment of the cannabidiol isolate novel food application NF 2021/2340 and set an internal completion deadline of 20 June 2026. This mid-2026 deadline clarifies the EU decision horizon for CBD as a novel food ingredient, giving manufacturers and retailers a clearer window for planning CBD-containing products and monitoring the eventual EFSA opinion and any authorisation decision.
US Senate Introduces S.4315 To Preserve State and Tribal Hemp Laws Under the Agricultural Marketing Act
US Senator Rand Paul has introduced S.4315 to amend the Agricultural Marketing Act of 1946 so that certain State and Tribal hemp laws are explicitly maintained, with the bill now before the Senate Agriculture, Nutrition, and Forestry Committee. If enacted, it could reshape the balance between federal and local oversight of hemp production and hemp-derived products, requiring multi-state operators to track and comply with a wider range of State and Tribal rules.
United States Amends Hemp Definition and Restricts Hemp-Derived Cannabinoid Products
A 2026 US appropriations law amends the federal hemp definition and introduces strict new thresholds and exclusions for hemp-derived cannabinoid products, including a 0.4 mg per-container cap on THC and THC-like cannabinoids and the exclusion of many synthetic or chemically modified cannabinoids from the “hemp” category. This will force rapid reformulation and relabelling across hemp, CBD, and cannabinoid product lines, narrow what can be marketed as federally compliant hemp, and sharpen FDA’s enforcement framework once the rules take effect in late 2026.
US Congress Proposes FD&C Act Framework for Cannabinoid Hemp Products (H.R. 7212)
US lawmakers have introduced H.R. 7212 to amend the Federal Food, Drug, and Cosmetic Act and create a comprehensive FDA-supervised framework for cannabinoid hemp products across oral, inhalable, and topical formats. If enacted, manufacturers, importers, and retailers of hemp-derived cannabinoids would face uniform federal standards for potency, manufacturing, testing, labelling, facility registration, age-of-sale, and recall, reshaping compliance expectations in this fast-growing category.
Czech Republic Reports Delta‑9‑THC in Jelly Candies From the Netherlands via RASFF
In April 2026, Czech authorities issued an EU RASFF alert after detecting delta-9-THC in jelly candies originating from the Netherlands. This underscores heightened enforcement against cannabis-derived ingredients in confectionery and continued market-risk exposure for food brands using or tolerating THC residues in EU products.
Illinois Proposes SB3820 to Align Hemp and Cannabis Law With Federal Changes
Illinois legislators have introduced SB3820 to update the Industrial Hemp Act and Cannabis Control Act so that state definitions of hemp, industrial hemp, THC, and hemp‑derived cannabinoid products align with recent federal law and to mandate follow‑on rulemaking. If enacted, the Illinois Department of Agriculture would need to revise hemp licensing, testing, and product rules within a year of the Act’s effective date, signalling tighter, federally aligned oversight for hemp growers and processors of hemp‑derived cannabinoid products in the state.
Minnesota Bills SF4871/HF4733 Propose Definition and Disclosure Rules for Remediated Cannabis Products
In March 2026 Minnesota lawmakers introduced companion bills SF4871/HF4733 to define remediated cannabis products and mandate prominent labelling, marketing disclosures, and a penalty framework for businesses selling such products. If adopted, cannabis producers and retailers that remediate batches to meet testing standards will need tighter tracking of remediation, packaging and marketing updates, and controls to avoid fines or licence suspension for non-disclosure.
Oklahoma HB 4248 Would Prohibit Sale of Hemp Beverages to Persons Under 21
Oklahoma House Bill 4248 would prohibit sales of beverages containing hemp to anyone under 21, has passed the House, and is now on the Senate calendar following committee approval in April 2026. If enacted with its proposed 1 November 2026 effective date, beverage manufacturers and retailers selling hemp-based drinks in Oklahoma will need to treat them as age-restricted products, tighten age-verification at point of sale, and monitor further state guidance on definitions and enforcement.
Maryland HB1631 Proposes Hemp Manufacturing License and Chain-of-Custody Rules
Maryland lawmakers are considering HB1631, introduced in February 2026, which would create a state hemp manufacturing license with strict chain-of-custody, testing, and documentation requirements for in-process hemp extract and finished hemp-derived products, now pending before the House Economic Matters Committee. If enacted, hemp and cannabinoid manufacturers serving Maryland would need to secure this license, overhaul recordkeeping and lab testing workflows, and ensure THC limits and documentation can support an affirmative defence in cannabis-related enforcement and investigations.
Related topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Cannabinoids alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at